Angelini Pharma SpA - Company Profile
Powered by 
All the data and insights you need on Angelini Pharma SpA in one report.
$295
- Save hours of research time and resources with
our up-to-date Angelini Pharma SpA Strategy Report
- Understand Angelini Pharma SpA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Angelini Pharma Spa (Angelini Pharma) manufactures, markets and commercializes pharmaceutical and healthcare products. The company operates in prescription and over-the-counter (OTC) pharmaceutical sectors with a focus on pain and inflammation disorders, traveler's diarrhea, infection control and infectious diseases, bacterial infections, mental health, and central nervous system diseases and disorders. Its products include benzydamine, trazodone, paracetamol, progesterone, glycerin, tetrahydrozoline, lactitol and prulifloxacin, among others. The company offers its products through brands such as Andolex, Trittico, Aulin, Tachipirina, Tantum, Lono, Vantal to Hospitals, Research Centers, Pharma Biotech and Contract Research Organizations. It operates manufacturing facilities in Italy, Spain and the US. Angelini Pharma is headquartered in Rome, Italy.
Headquarters
Italy
Address
Viale Amelia 70, Rome, Lazio, 00181
Website
www.angelinipharma.com
No of Employees
3,000
Industry
Pharmaceuticals and Healthcare
Angelini Pharma SpA premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Benzydamine | Andolex |
| Trazodone | Trittico |
| Paracetamol | Aulin |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Acquisitions/Mergers/Takeovers | In June, Angelini Industries acquired 100% stake of Fameccanica. |
| 2023 | Plans/Strategy | In May, the company announced its plans to invest up to US$505.5 million to fund development of a new treatment for epilepsy by Japan's JCR Pharmaceuticals. |
| 2023 | Contracts/Agreements | In March, the company entered into an agreement with IBE to assist epileptic ladies. |
Competitor Comparison
| Key Parameters | Angelini Pharma SpA | A. Menarini Industrie Farmaceutiche Riunite Srl | Alfasigma SpA | Chiesi Farmaceutici SpA | Shedir Pharma Srl |
|---|---|---|---|---|---|
| Headquarters | Italy | Italy | Italy | Italy | Italy |
| City | Rome | Florence | Bologna | Parma | Mercato San Severino |
| State/Province | Lazio | Toscana | Emilia-Romagna | Emilia-Romagna | - |
| No. of Employees | 3,000 | 17,000 | 2,900 | 6,500 | 74 |
| Entity Type | Private | Private | Private | Private | Public |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Jacopo Andreose | Chief Executive Officer | Senior Management | 2023 | - |
| Silvestro Camerini | Chief Financial Officer | Senior Management | 2020 | - |
| Rafal Kaminski | Head - Global R&D; Chief Scientific Officer | Senior Management | 2022 | - |
| Fabio De Luca | Chief Corporate Development Officer | Senior Management | 2020 | - |
| Enrico Giaquinto | Chief Industrial Operations Officer | Senior Management | 2019 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward